NASDAQ: AEHRAehr Test Systems Stock
$17.25-1.25 (-6.76%)
Updated Aug 16, 2022
AEHR Price
$17.25
Fair Value Price
$18.35
Market Cap
$464.42M
52 Week Low
$5.25
52 Week High
$27.09
P/E
107.81x
P/B
10.56x
P/S
9.57x
PEG
0.49x
Dividend Yield
N/A
Revenue
$38.18M
Earnings
$4.22M
Gross Margin
43.8%
Operating Margin
11.33%
Profit Margin
11.1%
Debt to Equity
0.3
Operating Cash Flow
$2M
Beta
1.12
Next Earnings
Sep 21, 2022
Ex-Dividend
N/A
Next Dividend
N/A
AEHR Overview
Zen Score
–
Industry Average (49)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AEHR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AEHR ($17.25) is undervalued by 6.01% relative to our estimate of its Fair Value price of $18.35 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AEHR ($17.25) is not significantly undervalued (6.01%) relative to our estimate of its Fair Value price of $18.35 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AEHR ($17.25) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AEHR due diligence checks available for Premium users.
AEHR News
Valuation
AEHR fair value
Fair Value of AEHR stock based on Discounted Cash Flow (DCF)
Price
$17.25
Fair Value
$18.35
Undervalued by
6.01%
AEHR ($17.25) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AEHR ($17.25) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AEHR ($17.25) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AEHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
107.81x
Industry
24.81x
Market
32.28x
AEHR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AEHR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
AEHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.56x
Industry
9.72x
AEHR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AEHR price to earnings growth (PEG)
For valuing profitable companies with growth potential
AEHR is good value based... subscribe to Premium to read more.
PEG Value Valuation
AEHR's financial health
Profit margin
Revenue
$15.3M
Net Income
$2.2M
Profit Margin
14.7%
AEHR's Earnings (EBIT) of $4.32M... subscribe to Premium to read more.
Interest Coverage Financials
AEHR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$57.4M
Liabilities
$13.4M
Debt to equity
0.3
AEHR's short-term assets ($55.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AEHR's short-term assets ($55.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AEHR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AEHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.9M
Investing
-$86.0k
Financing
$26.0k
AEHR's operating cash flow ($2.09M)... subscribe to Premium to read more.
Debt Coverage Financials
AEHR vs Semiconductor Equipment Stocks
Aehr Test Systems Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.